Last reviewed · How we verify
NCT04815499: EPOCAT
Effects of a Food Supplement on Quality of Life in Patients With Chronic Obstructive Pulmonary Disease.
NA trial testing Food supplement in Chronic Obstructive Pulmonary Disease in 18 participants. Completed in 3 November 2022.
15 September 2022
Quick facts
| Lead sponsor | Arafarma Group, S.A. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 18 |
| Start date | 14 January 2020 |
| Primary completion | 15 September 2022 |
| Estimated completion | 3 November 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Food supplement
- Placebo
Conditions studied
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
Sponsor
Arafarma Group, S.A. — full company profile →
Who can join
18 and older, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It has been demonstrated that consequences of malnutrition affect a situation of risk and have negative effects on the evolution of chronic obstructive pulmonary disease (COPD), accompanied by higher morbidity and mortality. The impact of malnutrition on the respiratory system affects the respiratory muscles, the lung parenchyma, and the immune system. In summary, the risk of complications can lead to a worsening of the quality of life of the COPD patient. Also, dyspnea as the main symptom of COPD is the one that produces the greatest loss of quality of life, especially in older patients. The components of our authorized food supplement improve the quality of life of the patient. These components maintain the strength and energy of the patient, help the body to recover and regain its optimal state, help improve the immune system, help reduce the side effects of therapies associated with the control or cure of cancer and help correct nutritional deficiencies. This is the reason why this experimental study aims to improve the quality of life in patients with COPD with a CAT score\>15.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04815499
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Food supplement
Trials testing the same drug.
- NCT06751810 — Nutritional Status in Children With Food Allergy: Evaluation of a New Supplement · NA · completed
- NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting
- NCT07199556 — Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors. · NA · completed
- NCT05718908 — Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement · completed
- NCT05525130 — Study of the Administration of a Food Supplement in Patients With Lithiasis Treated With Extracorporeal Shock Wave Litho · NA · completed
Other recruiting trials for Chronic Obstructive Pulmonary Disease
Currently open trials in the same condition.
- NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
- NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
- NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
- NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting
Other Arafarma Group, S.A. trials
Trials by the same sponsor.
- NCT07393958 — Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain. · NA · recruiting
- NCT07199556 — Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors. · NA · completed
- NCT05718908 — Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement · completed
- NCT05525130 — Study of the Administration of a Food Supplement in Patients With Lithiasis Treated With Extracorporeal Shock Wave Litho · NA · completed
- NCT05109455 — Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients. · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04815499 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arafarma Group, S.A.
- Last refreshed: 15 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04815499.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing